Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBC.1.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBC.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.9ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FY.9ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FY.9SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
FY.9SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FY.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.31.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.1.31.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.1.31.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.31.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.1.31.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.31.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
EG.9.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
EG.9.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EG.9.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
EG.9.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.22ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.2.3.22ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.2.3.22SWon-SCTACATGCACCAGCAACTGT20502311423133F-17500.9South Korea
XBB.2.3.22SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.2.3.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JV.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
JV.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
JV.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JV.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
JV.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JV.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.3.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.3.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.3.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used